Global Lisinopril Sales Market Report 2021
1 Lisinopril Market Overview
- 1.1 Lisinopril Product Scope
- 1.2 Lisinopril Segment by Type
- 1.2.1 Global Lisinopril Sales by Type (2016 & 2021 & 2027)
- 1.2.2 2.5mg
- 1.2.3 5mg
- 1.2.4 10mg
- 1.2.5 20mg
- 1.2.6 30mg
- 1.2.7 40mg
- 1.3 Lisinopril Segment by Application
- 1.3.1 Global Lisinopril Sales Comparison by Application (2016 & 2021 & 2027)
- 1.3.2 Hospital
- 1.3.3 Drug Store
- 1.4 Lisinopril Market Estimates and Forecasts (2016-2027)
- 1.4.1 Global Lisinopril Market Size in Value Growth Rate (2016-2027)
- 1.4.2 Global Lisinopril Market Size in Volume Growth Rate (2016-2027)
- 1.4.3 Global Lisinopril Price Trends (2016-2027)
2 Lisinopril Estimates and Forecasts by Region
- 2.1 Global Lisinopril Market Size by Region: 2016 VS 2021 VS 2027
- 2.2 Global Lisinopril Retrospective Market Scenario by Region (2016-2021)
- 2.2.1 Global Lisinopril Sales Market Share by Region (2016-2021)
- 2.2.2 Global Lisinopril Revenue Market Share by Region (2016-2021)
- 2.3 Global Lisinopril Market Estimates and Forecasts by Region (2022-2027)
- 2.3.1 Global Lisinopril Sales Estimates and Forecasts by Region (2022-2027)
- 2.3.2 Global Lisinopril Revenue Forecast by Region (2022-2027)
- 2.4 Geographic Market Analysis: Market Facts & Figures
- 2.4.1 North America Lisinopril Estimates and Projections (2016-2027)
- 2.4.2 Europe Lisinopril Estimates and Projections (2016-2027)
- 2.4.3 China Lisinopril Estimates and Projections (2016-2027)
- 2.4.4 Japan Lisinopril Estimates and Projections (2016-2027)
- 2.4.5 Southeast Asia Lisinopril Estimates and Projections (2016-2027)
- 2.4.6 India Lisinopril Estimates and Projections (2016-2027)
3 Global Lisinopril Competition Landscape by Players
- 3.1 Global Top Lisinopril Players by Sales (2016-2021)
- 3.2 Global Top Lisinopril Players by Revenue (2016-2021)
- 3.3 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Lisinopril as of 2020)
- 3.4 Global Lisinopril Average Price by Company (2016-2021)
- 3.5 Manufacturers Lisinopril Manufacturing Sites, Area Served, Product Type
- 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Lisinopril Market Size by Type
- 4.1 Global Lisinopril Historic Market Review by Type (2016-2021)
- 4.1.1 Global Lisinopril Sales Market Share by Type (2016-2021)
- 4.1.2 Global Lisinopril Revenue Market Share by Type (2016-2021)
- 4.1.3 Global Lisinopril Price by Type (2016-2021)
- 4.2 Global Lisinopril Market Estimates and Forecasts by Type (2022-2027)
- 4.2.1 Global Lisinopril Sales Forecast by Type (2022-2027)
- 4.2.2 Global Lisinopril Revenue Forecast by Type (2022-2027)
- 4.2.3 Global Lisinopril Price Forecast by Type (2022-2027)
5 Global Lisinopril Market Size by Application
- 5.1 Global Lisinopril Historic Market Review by Application (2016-2021)
- 5.1.1 Global Lisinopril Sales Market Share by Application (2016-2021)
- 5.1.2 Global Lisinopril Revenue Market Share by Application (2016-2021)
- 5.1.3 Global Lisinopril Price by Application (2016-2021)
- 5.2 Global Lisinopril Market Estimates and Forecasts by Application (2022-2027)
- 5.2.1 Global Lisinopril Sales Forecast by Application (2022-2027)
- 5.2.2 Global Lisinopril Revenue Forecast by Application (2022-2027)
- 5.2.3 Global Lisinopril Price Forecast by Application (2022-2027)
6 North America Lisinopril Market Facts & Figures
- 6.1 North America Lisinopril Sales by Company
- 6.1.1 North America Lisinopril Sales by Company (2016-2021)
- 6.1.2 North America Lisinopril Revenue by Company (2016-2021)
- 6.2 North America Lisinopril Sales Breakdown by Type
- 6.2.1 North America Lisinopril Sales Breakdown by Type (2016-2021)
- 6.2.2 North America Lisinopril Sales Breakdown by Type (2022-2027)
- 6.3 North America Lisinopril Sales Breakdown by Application
- 6.3.1 North America Lisinopril Sales Breakdown by Application (2016-2021)
- 6.3.2 North America Lisinopril Sales Breakdown by Application (2022-2027)
7 Europe Lisinopril Market Facts & Figures
- 7.1 Europe Lisinopril Sales by Company
- 7.1.1 Europe Lisinopril Sales by Company (2016-2021)
- 7.1.2 Europe Lisinopril Revenue by Company (2016-2021)
- 7.2 Europe Lisinopril Sales Breakdown by Type
- 7.2.1 Europe Lisinopril Sales Breakdown by Type (2016-2021)
- 7.2.2 Europe Lisinopril Sales Breakdown by Type (2022-2027)
- 7.3 Europe Lisinopril Sales Breakdown by Application
- 7.3.1 Europe 149 Sales Breakdown by Application (2016-2021)
- 7.3.2 Europe 149 Sales Breakdown by Application (2022-2027)
8 China Lisinopril Market Facts & Figures
- 8.1 China Lisinopril Sales by Company
- 8.1.1 China Lisinopril Sales by Company (2016-2021)
- 8.1.2 China Lisinopril Revenue by Company (2016-2021)
- 8.2 China Lisinopril Sales Breakdown by Type
- 8.2.1 China Lisinopril Sales Breakdown by Type (2016-2021)
- 8.2.2 China Lisinopril Sales Breakdown by Type (2022-2027)
- 8.3 China Lisinopril Sales Breakdown by Application
- 8.3.1 China 315 Sales Breakdown by Application (2016-2021)
- 8.3.2 China 315 Sales Breakdown by Application (2022-2027)
9 Japan Lisinopril Market Facts & Figures
- 9.1 Japan Lisinopril Sales by Company
- 9.1.1 Japan Lisinopril Sales by Company (2016-2021)
- 9.1.2 Japan Lisinopril Revenue by Company (2016-2021)
- 9.2 Japan Lisinopril Sales Breakdown by Type
- 9.2.1 Japan Lisinopril Sales Breakdown by Type (2016-2021)
- 9.2.2 Japan Lisinopril Sales Breakdown by Type (2022-2027)
- 9.3 Japan Lisinopril Sales Breakdown by Application
- 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
- 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Lisinopril Market Facts & Figures
- 10.1 Southeast Asia Lisinopril Sales by Company
- 10.1.1 Southeast Asia Lisinopril Sales by Company (2016-2021)
- 10.1.2 Southeast Asia Lisinopril Revenue by Company (2016-2021)
- 10.2 Southeast Asia Lisinopril Sales Breakdown by Type
- 10.2.1 Southeast Asia Lisinopril Sales Breakdown by Type (2016-2021)
- 10.2.2 Southeast Asia Lisinopril Sales Breakdown by Type (2022-2027)
- 10.3 Southeast Asia Lisinopril Sales Breakdown by Application
- 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
- 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Lisinopril Market Facts & Figures
- 11.1 India Lisinopril Sales by Company
- 11.1.1 India Lisinopril Sales by Company (2016-2021)
- 11.1.2 India Lisinopril Revenue by Company (2016-2021)
- 11.2 India Lisinopril Sales Breakdown by Type
- 11.2.1 India Lisinopril Sales Breakdown by Type (2016-2021)
- 11.2.2 India Lisinopril Sales Breakdown by Type (2022-2027)
- 11.3 India Lisinopril Sales Breakdown by Application
- 11.3.1 India Lisinopril Sales Breakdown by Application (2016-2021)
- 11.3.2 India Lisinopril Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Lisinopril Business
- 12.1 Actavis Elizabeth
- 12.1.1 Actavis Elizabeth Corporation Information
- 12.1.2 Actavis Elizabeth Business Overview
- 12.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.1.4 Actavis Elizabeth Lisinopril Products Offered
- 12.1.5 Actavis Elizabeth Recent Development
- 12.2 Apotex
- 12.2.1 Apotex Corporation Information
- 12.2.2 Apotex Business Overview
- 12.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.2.4 Apotex Lisinopril Products Offered
- 12.2.5 Apotex Recent Development
- 12.3 Aurobindo Pharma
- 12.3.1 Aurobindo Pharma Corporation Information
- 12.3.2 Aurobindo Pharma Business Overview
- 12.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.3.4 Aurobindo Pharma Lisinopril Products Offered
- 12.3.5 Aurobindo Pharma Recent Development
- 12.4 Ivax Pharmaceuticals
- 12.4.1 Ivax Pharmaceuticals Corporation Information
- 12.4.2 Ivax Pharmaceuticals Business Overview
- 12.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.4.4 Ivax Pharmaceuticals Lisinopril Products Offered
- 12.4.5 Ivax Pharmaceuticals Recent Development
- 12.5 Lek Pharmaceuticals
- 12.5.1 Lek Pharmaceuticals Corporation Information
- 12.5.2 Lek Pharmaceuticals Business Overview
- 12.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.5.4 Lek Pharmaceuticals Lisinopril Products Offered
- 12.5.5 Lek Pharmaceuticals Recent Development
- 12.6 Lupin
- 12.6.1 Lupin Corporation Information
- 12.6.2 Lupin Business Overview
- 12.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.6.4 Lupin Lisinopril Products Offered
- 12.6.5 Lupin Recent Development
- 12.7 Mylan Pharmaceuticals
- 12.7.1 Mylan Pharmaceuticals Corporation Information
- 12.7.2 Mylan Pharmaceuticals Business Overview
- 12.7.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.7.4 Mylan Pharmaceuticals Lisinopril Products Offered
- 12.7.5 Mylan Pharmaceuticals Recent Development
- 12.8 Ranbaxy Pharmaceuticals
- 12.8.1 Ranbaxy Pharmaceuticals Corporation Information
- 12.8.2 Ranbaxy Pharmaceuticals Business Overview
- 12.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.8.4 Ranbaxy Pharmaceuticals Lisinopril Products Offered
- 12.8.5 Ranbaxy Pharmaceuticals Recent Development
- 12.9 Novartis
- 12.9.1 Novartis Corporation Information
- 12.9.2 Novartis Business Overview
- 12.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.9.4 Novartis Lisinopril Products Offered
- 12.9.5 Novartis Recent Development
- 12.10 Teva Pharmaceuticals
- 12.10.1 Teva Pharmaceuticals Corporation Information
- 12.10.2 Teva Pharmaceuticals Business Overview
- 12.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.10.4 Teva Pharmaceuticals Lisinopril Products Offered
- 12.10.5 Teva Pharmaceuticals Recent Development
- 12.11 Vintage Pharmaceuticals
- 12.11.1 Vintage Pharmaceuticals Corporation Information
- 12.11.2 Vintage Pharmaceuticals Business Overview
- 12.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.11.4 Vintage Pharmaceuticals Lisinopril Products Offered
- 12.11.5 Vintage Pharmaceuticals Recent Development
- 12.12 Watson Laboratories
- 12.12.1 Watson Laboratories Corporation Information
- 12.12.2 Watson Laboratories Business Overview
- 12.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.12.4 Watson Laboratories Lisinopril Products Offered
- 12.12.5 Watson Laboratories Recent Development
- 12.13 West Ward Pharmaceutical
- 12.13.1 West Ward Pharmaceutical Corporation Information
- 12.13.2 West Ward Pharmaceutical Business Overview
- 12.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.13.4 West Ward Pharmaceutical Lisinopril Products Offered
- 12.13.5 West Ward Pharmaceutical Recent Development
- 12.14 Wockhardt
- 12.14.1 Wockhardt Corporation Information
- 12.14.2 Wockhardt Business Overview
- 12.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.14.4 Wockhardt Lisinopril Products Offered
- 12.14.5 Wockhardt Recent Development
- 12.15 Merck Research Laboratories
- 12.15.1 Merck Research Laboratories Corporation Information
- 12.15.2 Merck Research Laboratories Business Overview
- 12.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.15.4 Merck Research Laboratories Lisinopril Products Offered
- 12.15.5 Merck Research Laboratories Recent Development
- 12.16 Astrazeneca
- 12.16.1 Astrazeneca Corporation Information
- 12.16.2 Astrazeneca Business Overview
- 12.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.16.4 Astrazeneca Lisinopril Products Offered
- 12.16.5 Astrazeneca Recent Development
- 12.17 Alvogen
- 12.17.1 Alvogen Corporation Information
- 12.17.2 Alvogen Business Overview
- 12.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.17.4 Alvogen Lisinopril Products Offered
- 12.17.5 Alvogen Recent Development
- 12.18 Hikma
- 12.18.1 Hikma Corporation Information
- 12.18.2 Hikma Business Overview
- 12.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.18.4 Hikma Lisinopril Products Offered
- 12.18.5 Hikma Recent Development
- 12.19 Prinston
- 12.19.1 Prinston Corporation Information
- 12.19.2 Prinston Business Overview
- 12.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.19.4 Prinston Lisinopril Products Offered
- 12.19.5 Prinston Recent Development
- 12.20 Accord Hlthcare
- 12.20.1 Accord Hlthcare Corporation Information
- 12.20.2 Accord Hlthcare Business Overview
- 12.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.20.4 Accord Hlthcare Lisinopril Products Offered
- 12.20.5 Accord Hlthcare Recent Development
- 12.21 CASI Pharms
- 12.21.1 CASI Pharms Corporation Information
- 12.21.2 CASI Pharms Business Overview
- 12.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.21.4 CASI Pharms Lisinopril Products Offered
- 12.21.5 CASI Pharms Recent Development
- 12.22 Invagen Pharms
- 12.22.1 Invagen Pharms Corporation Information
- 12.22.2 Invagen Pharms Business Overview
- 12.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.22.4 Invagen Pharms Lisinopril Products Offered
- 12.22.5 Invagen Pharms Recent Development
- 12.23 SUN Pharm
- 12.23.1 SUN Pharm Corporation Information
- 12.23.2 SUN Pharm Business Overview
- 12.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2016-2021)
- 12.23.4 SUN Pharm Lisinopril Products Offered
- 12.23.5 SUN Pharm Recent Development
13 Lisinopril Manufacturing Cost Analysis
- 13.1 Lisinopril Key Raw Materials Analysis
- 13.1.1 Key Raw Materials
- 13.1.2 Key Raw Materials Price Trend
- 13.1.3 Key Suppliers of Raw Materials
- 13.2 Proportion of Manufacturing Cost Structure
- 13.3 Manufacturing Process Analysis of Lisinopril
- 13.4 Lisinopril Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
- 14.1 Marketing Channel
- 14.2 Lisinopril Distributors List
- 14.3 Lisinopril Customers
15 Market Dynamics
- 15.1 Lisinopril Market Trends
- 15.2 Lisinopril Drivers
- 15.3 Lisinopril Market Challenges
- 15.4 Lisinopril Market Restraints
16 Research Findings and Conclusion
17 Appendix
- 17.1 Research Methodology
- 17.1.1 Methodology/Research Approach
- 17.1.2 Data Source
- 17.2 Author List
The global Lisinopril market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lisinopril market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
2.5mg
5mg
10mg
20mg
30mg
40mg
Segment by Application
Hospital
Drug Store
The Lisinopril market is analysed and market size information is provided by regions (countries). Segment by Application, the Lisinopril market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Actavis Elizabeth
Apotex
Aurobindo Pharma
Ivax Pharmaceuticals
Lek Pharmaceuticals
Lupin
Mylan Pharmaceuticals
Ranbaxy Pharmaceuticals
Novartis
Teva Pharmaceuticals
Vintage Pharmaceuticals
Watson Laboratories
West Ward Pharmaceutical
Wockhardt
Merck Research Laboratories
Astrazeneca
Alvogen
Hikma
Prinston
Accord Hlthcare
CASI Pharms
Invagen Pharms
SUN Pharm